Prevalence of HER-2/neu amplification and trisomy 8 in stage I and III ovarian papillary serous carcinomas

被引：0
|
作者：
Afify, AM
Werness, IBA
Mark, HFL
机构：
[1] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[2] Roswell Pk Canc Inst, Buffalo, NY USA
[3] Rhode Isl Hosp, Providence, RI USA
来源：
LABORATORY INVESTIGATION | 1999年 / 79卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
642
引用
收藏
页码：111A / 111A
页数：1
相关论文
共 50 条
  • [31] Prognostic significance of HER-2/neu overexpression in stage I adenocarcinoma of lung
    Harpole, DH
    ANNALS OF THORACIC SURGERY, 1998, 66 (04): : 1163 - 1164
  • [32] HER-2/neu oncogene amplification by fluorescence in situ hybridization (FISH) in ovarian neoplasms.
    Yang, F
    Ambros, RA
    Kallakury, BVS
    Sheehan, CE
    Malfetano, JH
    Muraca, PJ
    Ross, JS
    MODERN PATHOLOGY, 1998, 11 (01) : 117A - 117A
  • [33] DNA AMPLIFICATION OF HER-2/NEU AND INT-2 ONCOGENES IN EPITHELIAL OVARIAN-CANCER
    MEDL, M
    SEVELDA, P
    CZERWENKA, K
    DOBIANER, K
    HANAK, H
    HRUZA, C
    KLEIN, M
    LEODOLTER, S
    MULLAUERERTL, S
    ROSEN, A
    SALZER, H
    VAVRA, N
    SPONA, J
    GYNECOLOGIC ONCOLOGY, 1995, 59 (03) : 321 - 326
  • [34] HER-2/neu gene amplification in neuroendocrine tumors and non-small cell carcinomas of the lung
    Pelosi, G
    Del Curto, B
    Dell'Orto, P
    Pasini, F
    Pastorino, U
    Iannucci, A
    Maffmi, F
    Viale, G
    LABORATORY INVESTIGATION, 2003, 83 (01) : 312A - 312A
  • [35] AMPLIFICATION AND OVEREXPRESSION OF HER-2/NEU IN CARCINOMAS OF THE SALIVARY-GLAND - CORRELATION WITH POOR-PROGNOSIS
    PRESS, MF
    HUNG, G
    PIKE, M
    GEORGE, J
    DIETZBAND, J
    JAMES, W
    SLAMON, DJ
    BATSAKIS, JG
    ELNAGGAR, AK
    LABORATORY INVESTIGATION, 1994, 70 (01) : A100 - A100
  • [36] Evaluation of overexpression of HER2/neu in primary uterine, ovarian, and peritoneal papillary serous carcinoma
    Hatami, M.
    Goldberg, G.
    Whitney, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] IMMUNOHISTOCHEMICAL HER-2/NEU EXPRESSION WITH GENE AMPLIFICATION BY FLUORESCENCE IN SITU HYBRIDIZATION FOR ASSESSMENT IN BREAST CARCINOMAS
    Moatter, Tariq
    Zeeshan-ud-din
    Khilji, Zahida Latif
    Murad, Farzana
    Kayani, Naila
    Pervez, Shahid
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2007, 17 (12): : 726 - 730
  • [38] AMPLIFICATION AND OVEREXPRESSION OF HER-2/NEU IN CARCINOMAS OF THE SALIVARY-GLAND - CORRELATION WITH POOR-PROGNOSIS
    PRESS, MF
    PIKE, MC
    HUNG, G
    ZHOU, JY
    MA, YL
    GEORGE, J
    DIETZBAND, J
    JAMES, W
    SLAMON, DJ
    BATSAKIS, JG
    ELNAGGAR, AK
    CANCER RESEARCH, 1994, 54 (21) : 5675 - 5682
  • [39] HER-2/neu gene amplification in neuroendocrine tumors and non-small cell carcinomas of the lung
    Pelosi, G
    Del Curto, B
    Dell'Orto, P
    Pasini, F
    Pastorino, U
    Iannucci, A
    Maffini, F
    Viale, G
    MODERN PATHOLOGY, 2003, 16 (01) : 312A - 312A
  • [40] Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu
    Tymon-Rosario, Joan
    Siegel, Eric R.
    Bellone, Stefania
    Harold, Justin
    Adjei, Naomi
    Zeybek, Burak
    Mauricio, Dennis
    Altwerger, Gary
    Menderes, Gulden
    Ratner, Elena
    Clark, Mitchell
    Andikyan, Vaagn
    Huang, Gloria S.
    Azodi, Masoud
    Schwartz, Peter E.
    Fader, Amanda N.
    Santin, Alessandro D.
    GYNECOLOGIC ONCOLOGY, 2021, 163 (01) : 93 - 99
12345